Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5'-monophosphate in asthma

Thorax

Volumn 53, Issue 6, 1998, Pages 483-489

  Taylor, D A ^a   McGrath, J L ^a   Orr, L M ^a   Barnes, P J ^a   O'Connor, B J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Airway responsiveness; Asthma; Nitric oxide

Indexed keywords

ADENOSINE PHOSPHATE; HISTAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SPASMOGEN;

ADULT; ARTICLE; ASTHMA; BREATHING MUSCLE; BRONCHODILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031802341     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.6.483     Document Type: Article

References (26)

1. Pavord ID, Tattersfield AK. Bronchoprotective role for endogenous prostaglandin E. Lancet 1996;345:436-8.
2. Ricciardolo FLM, Geppetti P, Mistretta A, et al. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 1996;348:374-7.
3. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:6369-73.
4. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995; 27:389-93.
5. Nathan C, Xie Q-W Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
6. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localisation. Am J Respir Cell Mol Biol 1993; 9:371-7.
7. Robbins RA, Barnes PJ, Springall DR, et al. Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem Biophys Res Commun 1994;203:209-18.
8. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343: 133-5.
9. Belvisi MG, Stretton CD, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways. Eur J Pharmacol 1992;210:221-2.
10. Ward JK, Belvisi MG, Fox AJ, et al. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest 1993;92:736-43.
11. Gruerter CA, Childers CC, Bosserman MK, et al. Comparison of relaxation induced by glyceryl trinitrate, isosorbide dinitrate, and sodium nitroprusside in bovine airways. Am Rev Respir Dis 1989;139:1192-7.
12. Hogman M, Frostell CG, Hedenstrom H, et al. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993;148:1474-8.
13. Nijkamp FP, Van Der Unde HJ, Folkerts G. Nitric oxide synthesis inhibitors induce airway hyper responsiveness in the guinea pig in vivo and in vitro. Am Rev Respir Dis 1993; 148:727-34.
14. Ricciardolo FLM, Nadel JA, Yoshihara S, et al. Evidence for reduction of bradykinin-induced bronchoconstriction in guinea-pigs by release of nitric oxide. Br J Pharmacol 1994, 113:1147-52.
15. Gaboury JP, Niu XF, Kubes P. Nitric oxide inhibits numerous features of mast cell induced inflammation. Circulation 1996;93:318-26.
16. Valentovic MA, Ball JG, Morenas M, et al. Influence of nitro vasodilators on bovine pulmonary histamine release. Pulmonol Pharmacol 1992;5:97-102.
17. Kaliner M. Asthma and mast cell activation. J Allergy Clin Immunol 1989;83:510-20.
18. Cushley MJ, Holgate ST. Adenosine-induced bronchoconstriction in asthma: role of mast cell mediator release. J Allergy Clin Immunol 1985;75:272-8.
19. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-26.
20. Yates DH, Kharitonov SA, Thomas PS, et al. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 1996;154:247-50.
21. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
22. Chai H, Farr RS, Froehich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975,56:323-7.
23. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancer 1993;342: 1510-3.
24. Mann JS, Cushley MJ, Holgate ST. Adenosine-induced bronchoconstriction in asthma: role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis 1985;132:1-6.
25. Holtzman MJ, Sheller JR, DiMeo M, et al. Effect of ganglionic blockade on bronchial reactivity in atopic subjects. Am Rev Respir Dis 1980;122:17-25.
26. 2 agonists: greater protection against adenosine monophosphate-than methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1994;150:381-7.